Dive Brief:

• Shire Pharmaceuticals — the manufacturer of Adderall — has agreed to a settlement of $56.5 million in response to claims that it falsely marketing the drug. 
• According to the claims, Shire violated the False Claims Act from 2004 to 2007 by stating the drug could prevent poor academic performance, criminal activity, traffic accidents, and sexually transmitted diseases. 
• The company didn't have scientific data to back up the claims it made about Adderral in public statements and marketing. 

Dive Insight: 

A lesson to all brands and marketers: Double check the truth of claims made. With something as serious as a pharmaceuticals, marketers need to be 100% certain what they are promoting has science to back it up. Now Shire is paying the price for overstating the drug's benefits, which is something that easily could have been avoided.